Tianjin Ringpu Bio-Technology Co.,Ltd. Share Price

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote 19/08/2026 5-day change 1st Jan Change
18.41 CNY -2.28% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. -7.21% -1.92%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 8.36B 1.24B 1.07B 995M 913M 1.72B 119B 1.74B 11.74B 4.6B 59.53B 4.66B 4.56B 197B P/E 2026 *
19.2x
P/E 2027 * 16.9x
Enterprise Value 8.88B 1.32B 1.13B 1.06B 969M 1.82B 126B 1.85B 12.47B 4.88B 63.23B 4.95B 4.84B 209B EV / Sales 2026 *
2.37x
EV / Sales 2027 * 2.06x
Free-Float
51.96%
Yield 2026 *
1.63%
Yield 2027 * 2.63%
06-09 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-28 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
29/10/25 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/10/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/08/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/07/25 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
13/06/25 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/04/25 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
29/04/25 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
1 day-2.28%
1 week-7.21%
Current month+8.17%
1 month+16.01%
3 months+7.22%
6 months-2.80%
Current year-1.92%
1 week 18.37
Extreme 18.37
19.95
1 month 15.43
Extreme 15.43
20.26
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
23.71
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 29/03/2023
Director of Finance/CFO 51 27/04/2022
Corporate Officer/Principal 45 26/10/2020
Director TitleAgeSince
Chairman 63 11/05/2008
Director/Board Member 53 24/12/2019
Director/Board Member 51 09/01/2020
Date Insider Type Main position Quantity % Market Cap.
24/05/23 Buy 3,000 0.0009%
23/05/23 Buy 1,000 0.0003%
04/09/20 Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-2.28%-7.21%-20.99%+4.19% 1.24B
+3.68%+4.27%-50.74%-57.77% 31.69B
+3.64%+10.71%+39.84%+110.84% 12.24B
-2.19%-0.70%-17.53%+5.74% 3.88B
-0.15%-0.45%-3.37%+24.76% 3.23B
-2.52%-4.51%+43.34%+37.20% 2.13B
-0.14%-1.13%+9.26%+17.07% 1.97B
+2.28%+4.85%+11.27%+133.93% 1.44B
-1.91%+0.30%-12.91%-42.95% 1.01B
-0.42%+0.14%-5.56%-22.31% 971M
Average -0.00%+1.22%-0.74%+21.07% 5.98B
Weighted average by Cap. +2.42%+4.42%-18.68%-2.11%

Financials

2026 *2027 *
Net sales 3.75B 557M 478M 446M 409M 770M 53.25B 783M 5.27B 2.06B 26.71B 2.09B 2.05B 88.31B 4.22B 627M 538M 502M 461M 866M 59.9B 880M 5.92B 2.32B 30.04B 2.35B 2.3B 99.33B
Net income 427M 63.39M 54.37M 50.77M 46.58M 87.6M 6.06B 89.04M 599M 235M 3.04B 238M 233M 10.05B 508M 75.43M 64.71M 60.42M 55.44M 104M 7.21B 106M 713M 279M 3.62B 283M 277M 11.96B
Net Debt 519M 77.15M 66.18M 61.8M 56.7M 107M 7.37B 108M 729M 286M 3.7B 290M 283M 12.23B 337M 50.06M 42.94M 40.1M 36.79M 69.18M 4.78B 70.32M 473M 185M 2.4B 188M 184M 7.93B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
19/08/26 CN¥18.41 -2.28% 8,546,214
18/08/26 CN¥18.84 -0.37% 6,299,325
17/08/26 CN¥18.91 -1.77% 6,564,900
14/08/26 CN¥19.25 -2.18% 10,343,448
13/08/26 CN¥19.68 -0.81% 14,285,721
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
18.41CNY
Average target price
20.41CNY
Spread / Average Target
+10.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock